461 related articles for article (PubMed ID: 16935386)
21. Establishment of cell lines using a doxycycline-inducible gene expression system to regulate expression of hepatitis B virus X protein.
Tang H; Liu L; Liu FJ; Chen EQ; Murakami S; Lin Y; He F; Zhou TY; Huang FJ
Arch Virol; 2009; 154(7):1021-6. PubMed ID: 19495936
[TBL] [Abstract][Full Text] [Related]
22. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
[TBL] [Abstract][Full Text] [Related]
23. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
24. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
Ogura N; Ogawa K; Watashi K; Ito T; Wakita T
Biochem Biophys Res Commun; 2018 Mar; 498(1):64-71. PubMed ID: 29481805
[TBL] [Abstract][Full Text] [Related]
25. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
26. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
27. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
Dong Q; Liu Z; Chen Y; Chan CY; Lin MC; Kung HF; Chan HL; Sung JJ; He ML
J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966
[TBL] [Abstract][Full Text] [Related]
28. [Adenovirus-mediated transduction of HBV/C genome into HepG2 cell line].
Zhou B; Liang MF; Li WD; Wang C; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1764-7. PubMed ID: 18971166
[TBL] [Abstract][Full Text] [Related]
29. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
[TBL] [Abstract][Full Text] [Related]
30. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
31. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
32. Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery.
Jia F; Zhang YZ; Liu CM
J Biotechnol; 2007 Jan; 128(1):32-40. PubMed ID: 17049658
[TBL] [Abstract][Full Text] [Related]
33. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.
Ren GL; Bai XF; Zhang Y; Chen HM; Huang CX; Wang PZ; Li GY; Zhang Y; Lian JQ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1051-9. PubMed ID: 16111658
[TBL] [Abstract][Full Text] [Related]
34. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
[TBL] [Abstract][Full Text] [Related]
35. Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro.
Favre D; Petit MA; Trépo C
ALTEX; 2003; 20(3):131-42. PubMed ID: 12947486
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
37. Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.
Cheng X; Guan W; Sun S; Li B; Li H; Kang F; Kang J; Yang D; Nassal M; Sun D
PLoS One; 2015; 10(12):e0145746. PubMed ID: 26699621
[TBL] [Abstract][Full Text] [Related]
38. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells.
Qu J; Lin J; Zhang S; Zhu Z; Ni C; Zhang S; Gao H; Zhu M
Biochem Biophys Res Commun; 2009 Aug; 386(3):504-9. PubMed ID: 19540192
[TBL] [Abstract][Full Text] [Related]
39. [Construction of plasmid stably expressing shRNA and inhibition of HBV replication and expression].
Zhang HB; Wu J; Zheng WL; Ma WL; Xian J; Xie WY; Li W; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):898-900. PubMed ID: 17908493
[TBL] [Abstract][Full Text] [Related]
40. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
